Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section

The investigators designed a prospective randomized study to investigate the efficacy of intravenous (IV) preemptive versus preventive paracetamol on postoperative pain scores, patient satisfaction, total morphine consumption and the incidence of morphine-related side effects in patients undergoing cesarean section.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cesarean Section; Dehiscence

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

38 weeks pregnancy, elective cesarean section.

Exclusion criteria

morbid obesity, cardiac failure, depression.

Treatment and study plan

Paracetamol was given intravenously in both group at different times

Drug

Primary outcomes

Visual analog score (VAS) for pain

Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Baskent University

Other

Registry information

Official study title

A Double Blind Randomised Controlled Trial of Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Mar 21, 2016
Registry last updated: Mar 21, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed